Latest filing published 08 Jan 2026 for Cartesian Therapeutics, Inc., €138k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Carsten Brunn on record concern Cartesian Therapeutics, Inc. Between 1 June 2021 and 6 January 2026, the trades on record add up to 25 filings.
The open-market record consists of 9 sales worth €461k, with no purchase. The rest of the record consists of 8 share grants and 7 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 8 January 2026, the filings show an open-market sale worth €138k in Cartesian Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations